natgillin/translations-raw huggingface dataset:
The recommended dose at initiation in adults and adolescents is 400-600 mg/day taken orally in two or three divided doses and this dose can be increased rapidly to 800-1200 mg/day in two or three divided doses.
Preporučena doza na početku liječenja u odraslih i adolescenata iznosi 400 – 600 mg/dan peroralno, podijeljena u dvije ili tri doze, a brzo se može povisiti na dozu od 800 – 1200 mg/dan podijeljenu u dvije ili tri doze.
The recommended dose can be used for elderly patients and for patients with kidney or liver problems.
Preporučenu dozu mogu koristiti stariji bolesnici i bolesnici s oštećenjem bubrega i jetre.
The recommended dose depends on the disease Simponi is used to treat and the response of the patient.
Preporučena doza ovisi o bolesti koja se liječi lijekom Simponi i o odgovoru bolesnika.
The recommended dose for
Preporučena doza za
The recommended dose for adolescents is 10 ml solution (corresponding to 10 mg aripiprazole) once a day.
Preporučena doza za adolescente je 10 ml otopine (što odgovara 10 mg aripiprazola) jedanput dnevno.
The recommended dose for adults is 100 mg twice daily for 24 weeks.
Preporučena doza za odrasle iznosi 100 mg dva puta dnevno, tijekom 24 tjedna.
The recommended dose for adults is 100 mg.
Preporučena doza za odrasle je 100 mg.
The recommended dose for adults is 15 ml solution (corresponding to 15 mg aripiprazole) once a day.
Preporučena doza za odrasle je 15 ml otopine (što odgovara 15 mg aripiprazola) jedanput dnevno.
The recommended dose for adults is 300 mg given once every 4 weeks.
Preporučena doza za odrasle je 300 mg svaka 4 tjedna.
The recommended dose for adults with primary disease is either 140 mg every two weeks or 420 mg (the contents of three pre-filled syringes) once a month.
Preporučena doza za odrasle osobe s primarnom bolešću iznosi 140 mg svaka dva tjedna ili 420 mg (sadržaj tri napunjene štrcaljke) jednom mjesečno.
The recommended dose for an adult or an adolescent 12 years and above is:
Preporučena doza za odrasle ili adolescente dobi od 12 i više godina je:
The recommended dose for cats is 25 mg indoxacarb/kg body weight, equivalent to 0.128 ml/kg body weight.
Preporučena dnevna doza je 25 mg indoksakarba/kg tjelesne mase, što je ekvivalent za 0,128 ml/kg tjelesne mase.
The recommended dose for children (age 2 to 12 years) is 375 mg/m2 Aptivus co-administered with 150 mg/m2 ritonavir, twice daily.
Preporučena doza za djecu (u dobi 2 do 12 godina) je 375 mg/m2 Aptivusa sa 150 mg/m2 ritonavira, dvaput dnevno.
The recommended dose for children aged 1 month to 18 years is the same mg/kg dose as for adults i.e.
Preporučena doza za djecu u dobi od 1 mjeseca do 18 godina ista je mg/kg doza kao i za odrasle, tj.
The recommended dose for children and adolescents is 0.2 ml Fluenz, administered as 0.1 ml in each nostril.
Preporučena doza za djecu i adolescente je 0,2 ml cjepiva Fluenz, primjenjene kao 0,1 ml u svaku nosnicu.
The recommended dose for children and adolescents is 0.2 ml Pandemic influenza vaccine H5N1 MedImmune, administered as 0.1 ml in each nostril.
Preporučena doza za djecu i adolescente je 0,2 ml Pandemijskog cjepiva protiv influence H5N1 MedImmune, primijenjeno kao 0,1 ml u svaku nosnicu.
The recommended dose for dogs is 15 mg indoxacarb/kg body weight, equivalent to 0.077 ml/kg body weight.
Preporučena dnevna doza je 15 mg indoksakarba/kg tjelesne težine, što je ekvivalent za 0,077 ml/kg tjelesne težine.
The recommended dose for DUAVIVE is 0.45 mg conjugated oestrogens (CE) and 20 mg bazedoxifene taken as a single oral tablet, once daily.
Preporučena doza lijeka DUAVIVE je jedna tableta za peroralnu primjenu jedanput na dan od 0,45 mg konjugiranih estrogena (KE) i 20 mg bazedoksifena.
The recommended dose for each infusion is 3 mg per kilogram body weight.
Preporučena doza za svaku infuziju iznosi 3 mg po kilogramu tjelesne težine.
The recommended dose for Eylea is 2 mg aflibercept equivalent to 50 microlitres.
Preporučena doza lijeka Eylea je 2 mg aflibercepta, što odgovara 50 mikrolitara.
The recommended dose for Herceptin solution for injection in administration system is 600 mg.
Preporučena doza Herceptin otopine za injekciju u sustavu za primjenu iznosi 600 mg.
The recommended dose for Herceptin subcutaneous formulation in administration system is 600 mg irrespective of the patient’s body weight.
Preporučena doza formulacije lijeka Herceptin za supkutanu primjenu u sustavu za primjenu iznosi 600 mg, neovisno o tjelesnoj težini bolesnika.
The recommended dose for Herceptin subcutaneous formulation is 600 mg irrespective of the patient’s body weight.
Preporučena doza formulacije lijeka Herceptin za supkutanu primjenu iznosi 600 mg, neovisno o tjelesnoj težini bolesnika.
The recommended dose for Lucentis is 0.5 mg given as a single intravitreal injection.
Preporučena doza lijeka Lucentis je 0,5 mg u obliku pojedinačne intravitrealne injekcije.
The recommended dose for patients aged 12 years and over is two tablets twice a day (12 hours apart, a total of four tablets [800 mg of lumacaftor/500 mg of ivacaftor] per day).
Preporučena doza za bolesnike u dobi od 12 i više godina iznosi dvije tablete dvaput na dan (s razmakom od 12 sati, to je ukupno četiri tablete [800 mg lumakaftora/500 mg ivakaftora] na dan).
The recommended dose for patients receiving supportive care in advanced illness is 8 mg methylnaltrexone bromide (0.4 mL of solution) for patients weighing 38-61 kg or 12 mg (0.6 mL of solution) for patients weighing 62-114 kg.
Preporučena doza za bolesnike koji primaju suportivnu skrb za uznapredovalu bolest je 8 mg metilnaltreksonbromida (0,4 ml otopine) za bolesnike koji teže 38-61 kg, ili 12 mg (0,6 ml otopine) za bolesnike koji teže 62-114 kg.
The recommended dose for patients with long-term pain (except patients receiving supportive care for advanced illness) is 12 mg methylnalrexone bromide (0.6 mL of solution) given as an injection under the skin , as needed, but at least given 4 times a week and up to once a day (7 times a week).
Preporučena doza za bolesnike s dugoročnom boli (osim bolesnika koji primaju suportivnu skrb za uznapredovalu bolest) iznosi 12m g metilnaltreksonbromida (0,6 ml otopine) koja se primjenjuje injekcijom pod kožu, po potrebi, ali najmanje 4 puta tjedno i najviše jedanput dnevno (7 doza tjedno).
The recommended dose for patients with long-term pain (except patients receiving supportive care for advanced illness) is 12 mg methylnalrexone bromide (0.6 mL of solution) given as an injection under the skin, as needed, but at least given 4-times a week and up to once a day (7 times a week).
Preporučena doza za bolesnike s dugoročnom boli (osim bolesnika koji primaju suportivnu skrb za uznapredovalu bolest) iznosi 12 mg metilnaltreksonbromida (0,6 ml otopine) koja se primjenjuje injekcijom pod kožu, po potrebi, ali najmanje 4 puta tjedno i najviše jedanput dnevno (7 doza tjedno).
The recommended dose for Pegasys is 180 micrograms once weekly by subcutaneous administration in the abdomen or thigh given in combination with oral ribavirin or as monotherapy.
Preporučena doza za Pegasys je 180 mikrograma jedanput tjedno, supkutano u predjelu trbuha ili bedra u kombinaciji s peroralno primijenjenim ribavirinom ili kao monoterapija.
The recommended dose for the treatment of CLL, either as a single agent or in combination, is 420 mg (three capsules) once daily (see section 5.1 for details of the combination regimen).
Preporučena doza za liječenje kronične limfocitne leukemije, bilo u monoterapiji ili u kombinaciji, je 420 mg (tri kapsule) jedanput na dan (vidjeti dio 5.1 za detalje kombiniranog režima liječenja).
The recommended dose for the treatment of MCL is 560 mg (four capsules) once daily.
Preporučena doza za liječenje limfoma plaštenih stanica je 560 mg (četiri kapsule) jedanput na dan.
The recommended dose for the treatment of WM is 420 mg (three capsules) once daily.
Preporučena doza za liječenje Waldenströmove makroglobulinemije je 420 mg (tri kapsule) jedanput na dan.
The recommended dose for treatment of bleeding episodes and for the prevention of bleeding in patients undergoing surgery or invasive procedures is 90 µg (range 80 – 120 µg) per kg body weight at intervals of two hours (1.5 – 2.5 hours).
Preporučena je doza u liječenju epizoda krvarenja i u prevenciji krvarenja u bolesnika koji se podvrgavaju operativnom zahvatu ili invazivnim postupcima 90 µg (raspon 80 - 120 µg) po kg tjelesne težine u intervalu od dva sata (1,5 - 2,5 sata).
The recommended dose for you or your child will depend on your or your child’s age and weight.
Preporučena doza za Vas ili Vaše dijete ovisi o Vašoj dobi i težini ili dobi i težini Vašeg djeteta.
The recommended dose group had the fewest number of patients who experienced ADRs and IARs.
Najmanje bolesnika s nuspojavama i reakcijama povezanima s infuzijom bilo je u skupini koja je primala preporučenu dozu.
The recommended dose in adults is 6 g per day divided in 2 doses of 3 g per day.
Preporučena doza za odrasle je 6 g dnevno, podijeljeno u 2 doze od po 3 g na dan.
The recommended dose in haematological diseases ranges from 125 mg/m2/day (3.38 mg/kg/day) to 300 mg/m2/day (8.10 mg/kg/day) as a single daily infusion, administered from 2 up to 4 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 900 mg/m2 (24.32 mg/kg), during the time of the entire conditioning treatment.
Preporučena doza kod hematoloških bolesti je u rasponu od 125 mg/m2/dan (3,38 mg/kg/dan) do 300 mg/m2/dan (8,10 mg/kg/dan) u jednoj dnevnoj infuziji, primjenjenoj tijekom 2 do 4 uzastopna dana prije autologne TKMS ovisno o kombinaciji s drugim kemoterapijskim lijekovima, bez prekoračenja ukupne maksimalne kumulativne doze od 900 mg/m2 (24,32 mg/kg), tijekom cijelog pripremnog liječenja.
The recommended dose in hypercalcaemia (albumin-corrected serum calcium 12.0 mg/dl or 3.0 mmol/l) is a single dose of 4 mg zoledronic acid.
Preporučena doza kod hiperkalcijemije (serumski kalcij korigiran za albumin ≥ 12,0 mg/dl ili 3,0 mmol/l) je jednokratna doza od 4 mg zoledronatne kiseline.
The recommended dose in hypercalcaemia (albumin-corrected serum calcium ≥ 12.0 mg/dl or 3.0 mmol/l) is a single dose of 4 mg zoledronic acid.
Preporučena doza kod hiperkalcijemije (serumski kalcij korigiran za albumin ≥ 12,0 mg/dl ili 3,0 mmol/l) je jednokratna doza od4 mg zoledronatne kiseline.
The recommended dose in hypercalcaemia (albumin-corrected serum calcium ≥ 12.0 mg/dl or mmol/l) is a single dose of 4 mg zoledronic acid.
Preporučena doza kod hiperkalcemije (serumski kalcij korigiran za albumin ≥ 12,0 mg/dl ili 3,0 mmol/l) je jednokratna doza od 4 mg Zoledronatne kiseline.
The recommended dose in hypercalcaemia (albumin-corrected serum calcium  12.0 mg/dl or mmol/l) is a single dose of 4 mg zoledronic acid.
Preporučena doza kod hiperkalcemije (serumski kalcij korigiran za albumin ≥12,0 mg/dl ili 3,0 mmol/l) je jednokratna doza od 4 mg zoledronatne kiseline.
The recommended dose in infants aged 0 – 12 months is as follows: age less than 6 months: 6,700 U/m² BSA, age 6 – 12 months: 7,500 U/m² BSA,
Preporučena doza u dojenčadi dobi od 0 do 12 mjeseci jest: dojenčad mlađa od 6 mjeseci: 6700 U/m² tjelesne površine u dobi 6 – 12 mjeseci: 7500 U/m² tjelesne površine
The recommended dose in lymphoma is 370 mg/m2/day (10 mg/kg/day) divided in two daily infusions before allogeneic HPCT, without exceeding the total maximum cumulative dose of 370 mg/m2 (10 mg/kg), during the time of the entire conditioning treatment.
Preporučena doza je 370 mg/m2/dan (10 mg/kg/dan) podijeljena u dvije dnevne infuzije prije alogene TKMS, bez prekoračenja ukupne maksimalne kumulativne doze od 370 mg/m2 (10 mg/kg), tijekom cijelog pripremnog liječenja.
The recommended dose in patients with mild hepatic impairment is 80 mg.
Preporučeno doziranje kod bolesnika s blagim oštećenjem funkcije jetre je 80 mg.
The recommended dose in patients with thromboembolic complications is 1 mg/kg bw administered subcutaneously twice daily.
Preporučena doza u bolesnika s tromboembolijskim komplikacijama iznosi 1 mg/kg TT primijenjeno supkutano dva puta na dan.
The recommended dose in renal transplant patients is 1 g administered twice daily (2 g daily dose), i.e.
Preporučena doza za bolesnike s presađenim bubregom iznosi 1 g dvaput dnevno (dnevna doza od 2 g), tj.
The recommended dose in renal transplant patients is 1°g administered twice daily (2°g daily dose).
Preporučena doza za bolesnike s presađenim bubregom iznosi 1 g dvaput dnevno (dnevna doza od 2 g).
The recommended dose in solid tumours ranges from 120 mg/m2/day (3.24 mg/kg/day) to
Preporučena doza kod solidnih tumora je u rasponu od 120 mg/m2/dan (3,24 mg/kg/dan) do
The recommended dose in solid tumours ranges from 120 mg/m2/day (3.24 mg/kg/day) to
Preporučena doza kod solidnih tumora je u rasponu od 120 mg/m2/danu (3,24 mg/kg/dan) do
The recommended dose in solid tumours ranges from 150 mg/m2/day (6 mg/kg/day) to 350 mg/m2/day (14 mg/kg/day) as a single daily infusion, administered from 2 up to 3 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 1050 mg/m2 (42 mg/kg), during the time of the entire conditioning treatment.
Preporučena doza je u rasponu od 150 mg/m2/dan (6 mg/kg/dan) do 350 mg/m2/dan (14 mg/kg/dan) u jednoj dnevnoj infuziji, primjenjenoj tijekom 2 do 3 uzastopna dana prije autologne TKMS ovisno o kombinaciji s drugim kemoterapijskim lijekovima, bez prekoračenja ukupne maksimalne kumulativne doze od 1050 mg/m2 (42 mg/kg), tijekom cijelog pripremnog liječenja.
The recommended dose in the prevention of skeletal related events in patients with advanced malignancies involving bone is 4 mg zoledronic acid every 3 to 4 weeks.
Preporučena doza za prevenciju koštanih događaja u bolesnika s uznapredovalom zloćudnom bolešću koja je zahvatila kost je 4 mg zoledronatne kiseline svaka 3 do 4 tjedna.
The recommended dose is 0.05 mg per kilogram body weight once a day.
Preporučena doza iznosi 0,05 mg po kilogramu tjelesne težine jednom dnevno.
The recommended dose is 0.125 mg (0.1 mL of the diluted solution) administered by intravitreal injection to the affected eye once as a single dose.
Preporučena doza je 0,125 mg (0,1 ml razrijeđene otopine) primijenjena intravitrealnom injekcijom u zahvaćeno oko jednokratno.
The recommended dose is 0.125 mg in 0.1 mL of the solution administered by intravitreal injection to the affected eye once as a single dose.
Preporučena doza je 0,125 mg u 0,1 ml otopine, primijenjena intravitrealnom injekcijom u zahvaćeno oko jednokratno.
The recommended dose is 0.2 to 0.4 g/kg bw every 3 to 4 weeks.
Preporučena doza je 0,2-0,4 g/kg TT svaka 3-4 tjedna.
The recommended dose is 0.2-0.4 g/kg every three to four weeks.
Preporučena doza iznosi 0,2 - 0,4 g/kg svaka tri do četiri tjedna.
The recommended dose is 0.24 mg/kg body weight/day.
Preporučena doza je 0,24 mg/kg tjelesne težine na dan.
The recommended dose is 0.25 mg given every 24 hours, either in the morning or in the evening.
Preporučena doza je 0,25 mg svaka 24 sata koja se uzima ujutro ili navečer.
The recommended dose is 0.3 to 0.5 mg/kg body weight, i.e.
Preporučena doza je 0,3 do 0,5 mg/kg tjelesne težine, tj.
The recommended dose is 0.3-0.5 mg/kg body weight, i.e.
Preporučena doza je 0,3-0,5 mg/kg tjelesne težine, tj.
The recommended dose is 0.75 mg once weekly.
Preporučena doza je 0,75 mg jedanput na tjedan.
The recommended dose is 0.75 mg per kg of body weight, every 12 hours (twice daily).
Preporučena doza je 0,75 mg po kg tjelesne težine, svakih 12 sati (dva puta na dan).
The recommended dose is 1 mg per kg of body weight, every 12 hours (twice daily).
Preporučena doza je 1 mg po kg tjelesne težine, svakih 12 sati (dva puta na dan).
The recommended dose is 1 mg per kg of body weight.
Preporučena doza je 1 mg po kg tjelesne težine.
The recommended dose is 1 mg varenicline twice daily following a 1-week titration as follows:
Preporučena doza je 1 mg vareniklina dvaput na dan nakon jednotjedne titracije prema sljedećem rasporedu:
The recommended dose is 1 pre-filled pen (250 micrograms/0.5 mL) given as a single injection.
Preporučena doza je 1 napunjena brizgalica (250 mikrograma/0,5 ml) koja se daje u jednoj injekciji.
The recommended dose is 1 pre-filled syringe (250 micrograms/0.5 mL) given as a single injection.
Preporučena doza je napunjena štrcaljka (250 mikrograma/0,5 ml) koja se daje u jednoj injekciji.
The recommended dose is 1,000 mg (four tablets) once a day.
Preporučena doza je 1000 mg (četiri tablete) jednom na dan.
The recommended dose is 1.30 g/m2/day of the free base divided four times daily.
Preporučena doza je 1,30 g/m2/dan slobodne baze podijeljene u četiri puta na dan.
The recommended dose is 1.5 mg per kg of body weight, one time per day, or 1 mg per kg of body weight every 12 hours (twice daily), depending on the severity of the thrombosis.
Preporučena doza je 1,5 mg po kg tjelesne težine, jedanput na dan, ili 1 mg po kg tjelesne težine svakih 12 sati (dva puta na dan), ovisno o težini tromboze.
The recommended dose is 1.8 mg per kilogram body weight given by a 30-minute infusion (drip) into a vein every three weeks.
Preporučena je doza 1,8 mg po kilogramu tjelesne težine, koja se daje intravenskom infuzijom (drip) u trajanju od 30 minuta svaka tri tjedna.
The recommended dose is 10 mg of elotuzumab per kilogram of your body weight.
Preporučena doza je 10 mg elotuzumaba po kilogramu tjelesne težine.
The recommended dose is 10 mg once a day.
Preporučena doza je 10 mg jedanput na dan.
The recommended dose is 10 mg per kilogram body weight.
Preporučena doza jest 10 mg po kilogramu tjelesne težine.
The recommended dose is 10 mg rivaroxaban taken orally once daily.
Preporučena doza je 10 mg rivaroksabana peroralno jedanput na dan.
The recommended dose is 10 microlitre dispersion/kg by slow bolus intravenous injection, followed by a 10 ml bolus of sodium chloride 9 mg/ml (0.9%) or glucose 50 mg/ml (5%) solution for injection.
Preporučena doza je 10 mikrolitara disperzije/kg sporom intravenskom bolus injekcijom, nakon čega slijedi bolus od 10 ml 0,9%-tne (9 mg/ml) otopine natrijevog klorida ili 5% -tne (50 mg/ml) otopine glukoze za injekciju.
The recommended dose is 10 ml (two 5 ml spoonfuls) of oral solution once a day.
Preporučena doza je 10 ml (dvije žličice od 5 ml) oralne otopine jedanput na dan.
The recommended dose is 100 mg taken as needed approximately 15 to 30 minutes before sexual activity (See Section 5.1).
Preporučena doza je 100 mg uzeta prema potrebi, otprilike 15 do 30 minuta prije spolne aktivnosti (vidjeti dio 5.1).
The recommended dose is 100 mg taken as needed approximately 15 to 30minutes before sexual activity (See Section 5.1).
Preporučena doza je 100 mg uzeta prema potrebi, otprilike 15 do 30 minuta prije spolne aktivnosti (vidjeti dio 5.1).
The recommended dose is 100 mg.
Preporučena je doza 100 mg.
The recommended dose is 100 micrograms of parathyroid hormone administered once-daily
Preporučena doza je 100 mikrograma paratireoidnog hormona primijenjenog jednom dnevno.
The recommended dose is 11 mg per kilogram body
Preporučena doza iznosi 11 mg po kilogramu tjelesne težine, te infuzija mora trajati najmanje sat vremena.
The recommended dose is 11 mg/kg siltuximab given over 1 hour as an intravenous infusion administered every 3 weeks until treatment failure.
Preporučena doza siltuksimaba je 11 mg/kg primijenjena tijekom 1 sata kao intravenska infuzija koja se primijenjuje svaka 3 tjedna do neuspjeha liječenja.
The recommended dose is 11 milligrams per kilogram of body weight, given once every 3 weeks.
Preporučena doza je 11 miligrama po kilogramu tjelesne težine, primjenjeno jedanput svaka 3 tjedna.
The recommended dose is 12.5 mg/kg (with a dose range of 11–14 mg/kg) once daily as presented in the table below.
Preporučena doza je 12.5 mg/kg (uz raspon doze od 11 - 14 mg/kg) jednom dnevno, kako je prikazano u tablici u nastavku.
The recommended dose is 14 ml Telzir oral suspension (700 mg fosamprenavir) twice daily with 100 mg ritonavir (as capsule or oral solution) twice daily.
Preporučena doza je 14 ml Telzir oralne suspenzije (700 mg fosamprenavira) dva puta dnevno s 100 mg ritonavira (u obliku kapsule ili oralne otopine) dva puta dnevno.
The recommended dose is 150 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at Week 4.
Preporučena doza je 150 mg supkutanom injekcijom s početnom dozom u 0., 1., 2. i 3. tjednu, nakon čega slijedi mjesečna doza održavanja počevši od 4. tjedna.
The recommended dose is 150 mg by subcutaneous injection.
Preporučena doza je 150 mg potkožnom injekcijom.
The recommended dose is 150 mg given as a single injection under the skin as soon as possible after the start of an attack.
Preporučena doza je 150 mg i primjenjuje se kao jednokratna potkožna injekcija što je prije moguće nakon početka napadaja.
The recommended dose is 150 mg nintedanib twice daily administered approximately 12 hours apart.
Preporučena doza nintedaniba je 150 mg dvaput dnevno primjenjeno u razmaku od približno 12 sati.
The recommended dose is 150 mg taken once daily as 2 capsules of 75 mg (see sections 4.4 and 5.1).
Preporučena doza je 150 mg uzeta jedanput dnevno u obliku 2 kapsule od 75 mg (vidjeti dijelove 4.4 i 5.1).
The recommended dose is 150 mg taken once daily as 2 capsules of 75 mg (see sections 4.4 and 5.1).
Preporučena doza je 150 mg, jedanput dnevno u obliku 2 kapsule od 75 mg (vidjeti dijelove 4.4 i 5.1).
The recommended dose is 16 mg per kilogram body weight, which is given once a week for the first 8 weeks.
Preporučena doza je 16 mg po kilogramu tjelesne težine, a primjenjuje se jedanput na tjedan tijekom prvih 8 tjedana.
The recommended dose is 160 mg (4 capsules) once a day with water.
Preporuča se uzimanje doze od 160 mg (4 kapsule) jedanput na dan s vodom.
The recommended dose is 160 mg enzalutamide (four 40 mg capsules) as a single oral daily dose.
Preporučena doza je 160 mg enzalutamida (četiri kapsule od 40 mg) primijenjena kao jednokratna peroralna dnevna doza.
The recommended dose is 162 mg (the content of 1 pre-filled syringe) given once a week.
Preporučena doza je 162 mg (sadržaj 1 napunjene štrcaljke) jedanput tjedno.
The recommended dose is 180 microgram/kg administered as a bolus (rapid intravenous injection), followed by an infusion (drip solution) of 2 microgram/kg/minute for up to 72 hours.
Preporučena doza iznosi 180 mikrograma/kg primijenjena odjednom u bolusu (brza intravenska injekcija), nakon koje slijedi infuzija (drip otopina za infuziju) u dozi od 2 mikrograma/kg/min u trajanju do 72 sata.
The recommended dose is 185 mg/m2/day (5 mg/kg/day) as a single daily infusion before allogeneic HPCT, without exceeding the total maximum cumulative dose of 185 mg/m2 (5 mg/kg), during the time of the entire conditioning treatment.
Preporučena doza je 185 mg/m2/dan (5 mg/kg/dan) u jednoj dnevnoj infuziji prije alogene TKMS, bez prekoračenja ukupne maksimalne kumulativne doze od 185 mg/m2 (5 mg/kg), tijekom cijelog pripremnog liječenja.
The recommended dose is 185 mg/m2/day (5 mg/kg/day) as a single daily infusion, administered for 2 consecutive days before autologous HPCT, without exceeding the total maximum cumulative dose of 370 mg/m2 (10 mg/kg), during the time of the entire conditioning treatment.
Preporučena doza je 185 mg/kg/dan (5 mg/kg/dan) u jednoj dnevnoj infuziji, primjenjenoj tijekom 2 uzastopna dana prije autologne TKMS, bez prekoračenja ukupne maksimalne kumulativne doze od 370 mg/m2 (10 mg/kg), tijekom cijelog pripremnog liječenja.
The recommended dose is 2 mg exenatide once weekly.
Preporučena doza je 2 mg eksenatida jednom tjedno.
The recommended dose is 2 mg of pembrolizumab per kilogram of your body weight.
Preporučena doza je 2 mg pembrolizumaba po kilogramu Vaše tjelesne težine.
The recommended dose is 2 million IU/m2 administered subcutaneously three times a week (every other day) for both splenectomised and non-splenectomised patients.
Preporučena doza je 2 milijuna IU/m2 primijenjena supkutano triput na tjedan (svaki drugi dan) i za splenektomirane i za nesplenektomirane bolesnike.